Galectin

Galectin bound to N-acetyllactosamine dimer

Simple galectin structures of dimeric, tandem and chimeric galectins

Galectin is a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. These proteins share similarities in their carbohydrate recognition domains (CRDs) which allow them to specifically bind to beta-galactoside sugars, a property that underlies their biological functions. Galectins are involved in various cellular processes including apoptosis, immunomodulation, cell adhesion, and cancer progression and metastasis. They are expressed in numerous cell types and tissues, playing roles in both innate and adaptive immunity, influencing tumor growth, and contributing to the regulation of inflammatory responses.

Classification

Galectins are classified based on their structural characteristics and the organization of their CRDs. There are three main types:

• Proto-type galectins, which have one CRD and can form non-covalent dimers.
• Tandem-repeat galectins, which contain two CRDs in a single peptide chain.
• Chimera-type galectins, which have one CRD and a non-lectin N-terminal domain that can promote oligomerization.

Function

The functions of galectins are diverse and complex, largely due to their ability to cross-link glycoproteins. This cross-linking can influence cell signaling, modulate cell adhesion to the extracellular matrix (ECM), and regulate cell growth and apoptosis. In the immune system, galectins can bind to specific glycans on the surface of immune cells, affecting their activation and migration. In cancer, galectins are known to contribute to tumor immune evasion, angiogenesis, and metastasis by interacting with the ECM and influencing tumor-immune cell interactions.

Galectins in Disease

The expression of galectins has been linked to several diseases, including cancer, inflammatory diseases, and neurodegenerative diseases. Their role in cancer is dual; they can promote tumor progression by facilitating tumor cell survival, angiogenesis, and metastasis, but they can also enhance anti-tumor immunity under certain conditions. In inflammatory diseases, galectins can either promote or inhibit inflammation depending on the context, making them potential targets for therapeutic intervention. In neurodegenerative diseases, the role of galectins is less clear, but they are thought to be involved in neuroinflammation and the immune response to neuronal damage.

Therapeutic Potential

Given their involvement in critical biological processes and disease, galectins represent promising targets for therapeutic intervention. Inhibitors of galectins, particularly galectin-1 and galectin-3, are under investigation for the treatment of cancer and fibrosis. Additionally, because of their role in modulating immune responses, galectins are being explored as potential therapies for autoimmune diseases and as targets for anti-inflammatory drugs.

Research Directions

Research on galectins continues to uncover their complex roles in health and disease. Future studies are likely to focus on understanding the specific mechanisms by which galectins influence disease processes, identifying the full spectrum of galectin-glycan interactions, and developing galectin-based therapies. The challenge lies in the specificity of galectin inhibitors and the potential for unintended effects due to the broad roles of galectins in cellular physiology.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian